AKTX
Akari Therapeutics PlcCompany with tickers: AKTX
CIK
1541157
CUSIP
00972G207
Shares Outstanding
1,574,342
13F Activity (30d)
2 filings
1 filers
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $37,337
Total Shares: 7,250
Institutional Ownership Trend
12 quarters
Holder Concentration
Across 1 13F filersTop Holder
100.0%
of institutional value
Top 5
100.0%
of institutional value
Top 10
100.0%
of institutional value
HHI
10,000
Highly concentrated
Quarterly Activity
vs Mar 2, 2026
New
1
Increased
0
Decreased
0
Sold Out
3
Unchanged
0
Holder count:
-2
Institutional value:
-100.0%
Shares held:
-100.0%
Top New Positions
vs Mar 2, 2026| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| Mid IFP Advisors, Inc | 7,250 | $37,337 |
Top Sold-Out Positions
vs Mar 2, 2026| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| — Hoyoung Huh, M.D., Ph.D. | 18,199,697,667 | $171,805,145,976 | |
| — Samir R. Patel | 9,725,215,000 | $91,806,029,600 | |
| — Ray Prudo, M.D. | 8,391,326,467 | $79,214,121,848 |
| Holder | Value (USD) | % of 13F | Shares | Type | Discretion | Filed | Open | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mid IFP Advisors, Inc | $37,337 | 100.00% | 7,250 | Shares | Sole | 2026-04-13 | ||||
| No holders match your search. | ||||||||||